from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1503c/-

LFCtreatmentdescriptionclass of inhibitor

0.286

Amikacinug/mL Amikacintranslation

0.044

Cap5-10ug/mL Capreomycintranslation

-0.282

Rox10-50 ug/mL Roxithromycintranslation

-0.387

SM2-5 ug/mL Streptomycintranslation

-1.072

Tet5-10 ug/mL Tetracyclinetranslation

0.550

Rif0.2-5ug/mL Rifampicintranscription

0.746

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.320

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.055

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.156

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.976

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.720

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.100

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.201

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.823

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.281

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.594

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.383

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.614

KCN5-20 ug/mL Potassium cyaniderespiration

0.572

NaN30.2-2 mM Sodium aziderespiration

-1.858

Nigericin50 uM Nigericinrespiration

0.247

TRC10-150 ug/mL Triclosanrespiration

0.280

TRZ10-25 ug/mL Thioridazinerespiration

-1.377

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.086

menadione6-10 ug/mL Menadionerespiration

0.590

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.712

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.069

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.432

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.897

NRP_1Non-replicating persistence stage 1dosRassociated

-0.621

Amp0.2mg/mL AmpicillincellWall

1.040

Cephalexin20-100 ug/mL CephalexincellWall

0.763

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.191

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.330

EMB10-20 ug/mL EthambutolcellWall

-0.517

Eta12-40 ug/mL EthionamidecellWall

-0.845

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.209

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.302

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.188

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.405

BZA0.12 mg/mL BenzamidearomaticAmides

0.259

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.507

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.494

H2O24 mM hydrogen peroxideDNAdamaging

-0.034

Levo10 ug/mL LevofloxacinDNAdamaging

-0.173

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.488

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.116

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.202

UVUV-irradiationDNAdamaging

0.326

ARP41-4 ug/mL Antitubercular compound ARP4?

0.436

Antimycin12.5-50 ug/mL Antimycin A?

1.215

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.678

PA_110-50 ug/mL Antitubercular compound PA-1?

0.392

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.901

PA8240.2-2 ug/mL PA-824?

1.291

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.548

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.864

Verapamil50 uM Verapamil?

-1.797

mercaptoethanol2 mM 2-Mercaptoethanol?

0.418

methoxatin10-20 ug/mL Methoxatin?